NEW YORK (GenomeWeb News) – Lab21, a Cambridge, UK-based clinical lab and companion diagnostics developer, has purchased a majority share of molecular diagnostics firm Biotec Laboratories.

The Ipswich, UK-based diagnostics firm has focused on infectious diseases since its creation in 1993. It also has been distributing some of Lab21's diagnostics products through its global network of distributors in 80 countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.